Patient Care

The Longevity Center Introduces Ozone Shots as New Option for Prostate Health

The newly offered, targeted ozone injections are a minimally invasive therapy with potential benefits for prostate tissue and function GREENVILLE,…

2 weeks ago

CISOs in 9 Countries: Vendor AI and EHR Now Drive Most Healthcare Data Breaches

New Black Book Research flash survey of 427 hospital and health system security leaders finds 74% see EHR, AI and…

2 weeks ago

Rural Care Reimagined: Avel eCare Multipoint EMS Model Supports Stronger Hospitals and Communities

SIOUX FALLS, SD / ACCESS Newswire / December 9, 2025 / When a medical emergency happens in rural America, distance,…

2 weeks ago

Dimora Medical Recognized as Key Driver in Winner Medical’s Amazon Award

NEW YORK, Dec. 9, 2025 /PRNewswire/ -- Winner Medical, the parent company of Dimora Medical, has been honored with the Paid…

2 weeks ago

ChiroTouch Unveils Compliance Scan, Delivering AI-Powered Documentation Accuracy and Audit Protection to Chiropractors

SAN DIEGO--(BUSINESS WIRE)--#ChiroTouch--Claim denials and documentation errors can drain up to 30% of a chiropractic practice’s expected collections, creating significant…

2 weeks ago

Clinical Communication & Collaboration Market worth $5,302.9 million by 2030 | MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 8, 2025 /PRNewswire/ -- According to MarketsandMarkets™, the Clinical Communication & Collaboration Market is projected to grow…

2 weeks ago

Dr. Shawn Griffin recognized as one of Modern Healthcare’s 100 Most Influential People in Healthcare

WASHINGTON, Dec. 8, 2025 /PRNewswire/ -- URAC is proud to announce that its President and CEO, Shawn Griffin, MD, was recognized…

2 weeks ago

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its…

2 weeks ago

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to…

2 weeks ago